The Middle East and Africa Cell Expansion Market size have been calculated at USD 2.05 billion in 2022. This value is further projected to be growing at a CAGR of 14.9% and worth USD 4.10 billion by 2027.
The rising incidence of chronic diseases, government funding in cell-based research, the expanding focus on personalized medicine, increasing focus on R&D for cell-based therapeutics, and growing GMP certifications for cell therapy manufacturing facilities are driving growth in this market. In the development of drugs for the treatment of diseases, cell expansion is used. Vaccines, medicines, therapies, and antibiotics are all made with it. In addition, diseases like diabetes and cancer are becoming more common, necessitating more thorough studies to identify new treatment alternatives.
Chronic disorders like diabetes, rheumatoid arthritis, and cancer are on the rise, propelling the MEA cell expansion market forward. In addition, government agencies are releasing funding for stem cell research and other types of research, which will help the market for cell expansion systems grow. Multinational corporations are investing in the development of cell expansion systems because they reduce the danger of contamination, improve cell density, allow for controlled cell growth, and may be used in a regulated environment.
The MEA cell expansion industry has profitable opportunities due to the rise in opportunity in this region and the increased focus on personalized treatment. Cell expansion bioreactors are quick to set up and do not have to be cleaned or sterilized regularly. The advantage of employing cell expansion systems in the pharmaceutical, biotechnology, or research organizations is that they are extremely dependable and assure proper cell culture mixing and aeration. In CTP manufacturing, the paradigm change toward Single-Use Systems (SUS) offers significant productivity benefits. Cross-contamination and culture contamination caused by improper sterilization is no longer an issue with SUS. In the life sciences field, cellular therapies are continually gaining favor. The market is being driven by an increase in funding from private and government organizations and activities undertaken by them to support the development of cellular therapies. The International Society for Stem Cell Research works to identify stem cell-related funding opportunities in various biological fields.
The cell expansion market's growth in the MEA region may be hampered by ethical concerns about cell biology research, a scarcity of trained experts, and the high cost of cell-based treatments. Therefore, in the coming years, the market is expected to be constrained by a scarcity of skilled specialists and expensive initial costs. In addition, in the approaching years, a lack of high-tech instrumentation and 3D cell expansion technology is going to be a challenge.
This research report on the Middle East and Africa cell expansion market has been segmented and sub-segmented into the following categories.
By Product:
By Cell Type:
By Application:
By End-user:
By Country:
The expansion of the Middle East and Africa cell expansion market is fuelled by an increase in cell therapy transplantation procedures, increased research and development efforts, and increased investments in developing production facilities for cell and gene therapy products. Furthermore, due to an increase in government financing initiatives, which has accelerated the synthesis of stem cells and the development of regenerative medicine and cellular therapy products. As a result, demand for cell expansion platforms in this region is on the rise.
KEY MARKET PLAYERS:
Some of the prominent companies leading the Middle East & Africa cell expansion market profiled in the report include Beckman Coulter, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.2.1 Reagents. Media & Serum
5.1.3 Instruments
5.1.3.1 Cell Expansion Supporting Equipment
5.1.3.2 Bioreactors
5.1.3.3 Automated Cell Expansion Systems
5.1.4 Disposables
5.1.4.1 Tissue Culture Flasks
5.1.4.2 Bioreactor Accessories
5.1.4.3 Other Disposables
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Cell Type
5.2.1 Introduction
5.2.2 Human Cells
5.2.2.1 Stem Cells
5.2.2.2 Differenciated Stem Cells
5.2.3 Animal Cells
5.2.4 Y-o-Y Growth Analysis, By Cell Type
5.2.5 Market Attractiveness Analysis, By Cell Type
5.2.6 Market Share Analysis, By Cell Type
5.3 Application
5.3.1 Introduction
5.3.2 Regenerative Medicine & Stem Cell Research
5.3.3 Cancer and Cell-Based Research
5.3.4 Other Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Biotechnology & Pharmaceutical Companies
5.4.4 Academic Institutes & Research Facilities
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.6 Market Attractiveness Analysis, By End User
5.4.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Cell Type
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Cell Type
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Cell Type
6.1.5.4 By Application
6.1.5.5 By End User
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Beckman Coulter
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton, Dickinson and Company
8.3 Corning
8.4 GE Healthcare
8.5 Lonza
8.6 Merck KGaA
8.7 Miltenyi Biotec
8.8 STEMCELL Technologies
8.9 Terumo BCT
8.10 Thermo Fisher Scientific
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
